Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population

Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population

Subhasish Pramanik,1 Lakshmi Kanta Mondal,2 Suman Kalyan Paine,3 Sneha Jain,2 Subhankar Chowdhury,1 Upasana Ganguly,4 Sayantan Ghosh,2 Chiranjit Bose,1 Koena Bhattacharjee,2 Gautam Bhaduri5 1Institute of Post Graduate Medical Education and Research (IPGMER), Kolkata, 700020, India; 2Regional Institu...

Full description

Bibliographic Details
Main Authors: Pramanik S, Mondal LK, Paine SK, Jain S, Chowdhury S, Ganguly U, Ghosh S, Bose C, Bhattacharjee K, Bhaduri G
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Clinical Ophthalmology
Subjects:
diabetic retinopathy
diabetic macular edema
ranibizumab
bevacizumab
laser therapy
cost-effectiveness
Online Access:https://www.dovepress.com/efficacy-and-cost-effectiveness-of-anti-vegf-for-treating-diabetic-ret-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/efficacy-and-cost-effectiveness-of-anti-vegf-for-treating-diabetic-ret-peer-reviewed-fulltext-article-OPTH

Similar Items